Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of verapamil on type 2 diabetes mellitus
IRCT2016100925895N5Phase 2Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of verapamil in type 2 diabetes mellitus (T2DM), insulin resistance (IR) and hypertension (HTN), sponsored by Arak University of Medical Sciences. Started Nov 2016; status: completed.
02
Drugs
verapamil
03
Conditions
type 2 diabetes mellitus (T2DM)insulin resistance (IR)hypertension (HTN)
Beyond the preview
Go deeper on IRCT2016100925895N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016100925895N5.